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Purpose: An early and significant event in diabetic retinopathy is the loss of retinal microvascular pericytes. Studies were
performed to investigate pathways through which an advanced glycation endproduct and tumor necrosis factor (TNF)-α
stimulate apoptosis in retinal pericytes through the activation of the pro-apoptotic transcription factor Forkhead box O1
(FOXO1).
Methods: Human retinal pericytes were stimulated by carboxymethyllysine (CML)-collagen, an advanced glycation
endproduct, or TNF-α in vitro. Apoptosis was assessed by measuring cytoplasmic histone-associated DNA. The role of
FOXO1 was examined by RNA interference (RNAi), and specific inhibitors were used to investigate the role of p38 and
Jun N-terminal kinase mitogen-activated protein kinase (JNK MAP) kinases, Akt, and nuclear factor kappa B (NF-κB).
Caspase-3 activity was measured with a luminescent substrate, and FOXO1 DNA-binding activity was measured by
electrophoretic mobility shift assay (EMSA).
Results: TNF-α and CML-collagen but not control collagen stimulated apoptosis, caspase-3 activity, and FOXO1 DNA-
binding activity in pericytes. Silencing FOXO1 by small interfering RNA prevented apoptosis of pericytes in response to
both TNF-α and CML-collagen. By use of specific inhibitors, we demonstrated that both FOXO1 activation and subsequent
apoptosis was mediated, in part, by p38 and JNK MAP kinases. In contrast Akt and NF-κB inhibitors had the opposite
effect on pericyte apoptosis.
Conclusions: The results demonstrate pathways through which two different mediators, TNF-α and an advanced glycation
endproduct, can induce pericyte apoptosis through activation of the transcription factor FOXO1.
Diabetes mellitus is the most frequent endocrine disease,
causing  a  high  degree  of  morbidity  and  contributing  to
elevated rates of mortality. One of the principle long-term
complications of diabetes is microangiopathy, which affects
various organs and contributes to diseases such as diabetic
retinopathy,  neuropathy,  and  nephropathy  [1,2].  An  early
histopathologic feature of diabetic retinopathy is selective
degeneration of pericytes in the retinal capillary vessels. It has
been shown that pericytes of diabetic retinas undergo changes
consistent with apoptosis [3,4]. Pericytes do not replicate in
the adult retina and their degeneration contributes to increased
vascular permeability and retinal edema [5,6]. The loss of
pericytes  is  thought  to  result  in  focal  retinal  capillary
endothelial cell proliferation, leading to microaneurysms or
degeneration  of  endothelial  cells,  and  forming  acellular
capillaries, which can lead to subsequent formation of areas
of nonperfusion [7].
Mechanisms proposed to account for pericyte apoptosis
include formation of advanced glycation endproducts (AGE)
and retinal inflammation [8,9]. It has been shown that AGE
can induce dose- and time-dependent apoptotic effects on
pericytes [10]. Tumor necrosis factor (TNF)-α also has been
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found in human retinas with proliferative diabetic retinopathy
[11,12] and has been shown to induce apoptosis of retinal
endothelial cells [13]. Interestingly, anti-inflammatory drugs
prevent  early  events  in  diabetic  retinopathy  via  TNF-α
suppression [14], and TNF-α inhibition in vivo reduces the
loss of microvascular cells [9]. While AGE and inflammatory
signals may play an important role in the process of pericyte
apoptosis, it is important to consider that these events are
initiating signals, and therefore it is necessary to investigate
their downstream targets.
We recently demonstrated that both AGE and TNF-α can
promote  apoptosis  by  activation  of  the  Forkhead  box  O1
(FOXO1)  transcription  factor  that,  in  turn,  changes  the
balance  of  gene  expression  toward  apoptosis  [15-17].
Interestingly, high levels of FOXO1 have been reported in
diabetes, but the scope of these studies has focused on the
effect of FOXO1 on mRNA levels of genes that increase
glucose production, thereby contributing to hyperglycemia in
diabetes [18]. Since diabetes can increase FOXO1 activity and
potentiate cells toward apoptosis, it is logical to assume that
FOXO1 may also play a role in apoptosis of pericytes.
The  forkhead  box  class-O  (FOXO)  winged  helix
transcription  factors  are  orthologs  of  the  Caenorhabditis
elegans  forkhead  factor  DAF-16  [19,20].  Forkhead
transcription factors FOXO1, FOXO3, and FOXO4 (formally
known  as  FKHR,  FKHR-L1,  and  AFX,  respectively)
modulate apoptosis through gene expression [19,20]. FOXO1
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408activation, in particular, has a global effect on apoptotic gene
expression and induces approximately 25 pro-apoptotic genes
that  promote  cell  death  [17].  Furthermore,  FOXO1  is
activated in the retina of diabetic animals and its knockdown
significantly reduces formation of acellular capillaries and
formation of pericyte ghosts [21].
One possible pathway through which FOXO1 can be
activated  in  response  to  diabetes  is  through  the  mitogen-
activated protein (MAP) kinase pathway [22]. There are three
major  convergence  points  in  the  MAP  kinase  pathway
involving  p38,  c-Jun  NH2-terminal  kinase  (JNK),  and
extracellular signal-related protein kinase (ERK). p38 and
JNK in most cell types generate pro-apoptotic signals, while
ERK  mediates  typically  a  survival  (anti-apoptotic)  signal
[23,24]. The purpose of the experiments described here was
to  investigate  whether  FOXO1  plays  a  functional  role  in
apoptosis  of  retinal  pericytes  induced  by  TNF-α  and
carboxymethyllysine (CML)-collagen through in vitro studies
and to examine whether the MAP kinase pathway mediates
FOXO1  activation,  which  is  induced  by  both  stimuli  in
microvascular pericytes.
METHODS
Pericyte  cultures:  Primary  bovine  retinal  pericytes  were
purchased from VEC Technologies (Rensselaer, NY). Cells
were  cultured  in  Dulbecco’s  modiﬁed  Eagle's  medium
(DMEM) medium (Cambrex, Charles City, IA) supplemented
with 20% fetal bovine serum (FBS). Assays were performed
at passage 2 or 3. Prior to assay cells were incubated in serum-
free DMEM medium for 2 days. For all assays cells were
tested at approximately 70%–80% confluence in serum-free
medium. In some cases cells were preincubated for 2 h with
or without signaling inhibitors purchased from Calbiochem
(LaJolla, CA) as follows: p38 inhibitor SB203580 (4–4[4-
fluorophenyl]-2-[4-methylsulfinylphenyl]-5-[4-pyridyl]  1H-
imidazole), 10 μM [25]; the AKT inhibitor, triciribine, 1 μl
[26];  and  JNK  inhibitory  peptide  H-
GRKKRRQRRRPPRPKRPTTLNLFPQVPRSQDT-NH2
(L-HIV-TAT  48–57  PP-JBD20),  10  μM  [27].  The
concentrations of inhibitors were selected based on published
studies  [25-27].  The  same  approach  was  used  to  inhibit
nuclear  factor  (NF)-κB  with  the  specific  NF-κB  inhibitor
SN50 (100 μg/ml), which was compared to incubation with
SN50M  control  peptide  that  lacks  activity  (100  μg/ml;
Biomol, Plymouth Meeting, PA). For apoptosis assays cells
were incubated with TNF-α (R and D, Minneapolis, MN) or
CML-collagen with or without inhibitors or small interfering
(si)RNA for 24 h, as described below. For electrophoretic
mobility shift assay (EMSA), cells were incubated for 1 h in
assay medium with or without 20 ng/ml of TNF-α or CML-
collagen (200 μg/ml). Cells were then lysed with lysis buffer
(Pierce, Rockford, IL), nuclei obtained by centrifugation at
12,000x g for 10 min, and nuclear proteins isolated using
nuclear extraction buffer (25 mM Tris-HCl pH 7.6, 150 mM
NaCl, 1% NP-40, 1% Sodium deoxycholate and 0.1% SDS,
Pierce). For caspase-3 activity lysates were prepared using
cell  lysis  buffer  provided  by  R  and  D  systems.  After
centrifugation at 12,000x g for 10 min at 4 °C, total protein
was quantified using a bicinchoninic acid (BCA) protein assay
kit (Pierce). Caspase-3 activity was detected by using the
specific  caspace-3  fluorogenic  substrate  Asp-Glu-Val-Asp
(DEVD)  peptide  conjugated  to  7-amino-4-trifluoromethyl
coumarin. Measurements were made on a GENios microplate
reader (Tecan, Durham NC) using a filter for excitation (400
nm) and detection of emitted light (505 nm). Buffers without
cell lysate and cell lysates without substrate were used as
negative controls. Statistical significance was established by
ANOVA (ANOVA) with Tukey’s post hoc test.
CML-collagen: CML-collagen (AGE-collagen) was prepared
by chemical modification of acid-soluble bovine skin collagen
type-1 (Sigma, St Louis, MO), as previously described [28,
29]. Briefly, 50 mg of collagen was dissolved in 25 ml of 1 mM
HCl freshly made in sterile water and incubated at 37 °C with
occasional mixing. Sterile phosphate buffered saline (PBS;
PH  7.8,  25  ml)  was  added,  followed  by  sodium
cyanoborohydride  (1.42  g)  and  sodium  glyoxyliate  acid
(0.715 g). Control collagen was prepared at the same time
except that no glyoxyliate acid was added. All samples were
then incubated at 37 °C for 24 h. AGE collagen and control
collagen  were  then  exhaustively  dialyzed  against  distilled
water. Both CML-collagen and control collagen were soluble
at the concentrations stored and tested. In total, 3%–8% of
lysine residues in CML-collagen was converted to CML, as
determined by the trinitrobenzenesulfonic acid assay [30].
Based  on  this  level  of  modification,  200  μg/ml  of  CML-
collagen  would  represent  approximately  4.8  nmol/ml  of
carboxymethylysine,  which  approximates  the  levels  of
carboxymelthylysine reported in serum (approximately 2.6
nmol/ml) [31]. The collagen modification that we generated
is tenfold less than the amount reported to assess CML binding
and activation of NF-κB [28] and only a small amount higher
than  has  been  reported  for  the  skin  of  aged  or  diabetic
individuals  [32].  Low  levels  of  endotoxin  were  detected;
approximately 0.1 ng/ml in both control collagen and CML-
collagen samples.
Electrophoretic  mobility  shift  assay:  Interactions  between
nuclear proteins and FOXO1 DNA probe (CAAAACAA)
were  investigated  using  an  EMSA  kit  from  Panomics
(Redwood  City,  CA),  following  the  manufacturer’s
instruction and as previously reported [33]. Briefly, samples
were incubated with the biotin-labeled DNA probe, followed
by  separation  of  the  mixture  on  a  non-denaturing
polyacrylamide  gel  and  assessed  for  shifted  bands  that
correspond to the protein/DNA complexes. Specificity was
demonstrated for each by adding 60-fold molar excess of
unlabeled oligonucleotide. Each experiment was performed
two to three times with similar results.
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409Small  interfering  RNA  experiments:  Experiments  were
performed in retinal pericytes that were approximately 70%–
80% confluent, as described above. Cells were transfected
with siRNA (5 nM), by pre-mixing siRNA with Hiperfect
transfection reagent (Qiagen) and then adding the mixture to
cells  following  the  manufacturer’s  instructions.  siRNAs
specific  for  FOXO1  were  designed  by  Qiagen  to  be
nonhomologous with other genes. Two different FOXO1-
based siRNAs were used: strongly silencing (siRNA-A, AAG
CCC TGG CTC TCA CAG CAA) and partially silencing
(siRNA-B, AAG TTC ATT CGT GTG CAG AAT), which
correspond  to  sequences  previously  described  [17].  In
addition, scrambled siRNA (AAT TCT CCG AAC GTG TCA
CGT) was also used as a control. Apoptosis was measured by
detecting  cytoplasmic  histone-associated  DNA  (Roche,
Indianapolis, IN). Experiments were performed three times.
The statistical difference between samples was determined by
ANOVA followed by Tukey’s multiple comparison test.
RESULTS
In vitro experiments demonstrated that apoptosis is increased
in retinal pericytes with increased concentrations of TNF-α in
a dose-dependent manner (Figure 1A). TNF-α at 20 ng/ml
increased apoptosis in pericytes sevenfold compared with the
control,  which  was  statistically  significant  (p<0.05).
Similarly, CML-collagen induced a dose-dependent increase
in pericyte apoptosis, while control collagen did not (Figure
1B).  CML-collagen  compared  with  unmodified  collagen
induced a 2.9-fold increase in apoptosis (p<0.05; Figure 1B).
When caspase-3 activity was measured, a similar increase was
observed (Figure 1C). TNF-α (20 ng/ml) increased caspase-3
activity 7.8-fold compared to unstimulated cells, while CML-
collagen, compared with control collagen at a concentration
of 200 μg/ml, increased caspase activity 3.2-fold (p<0.05). In
subsequent studies a concentration of 20 ng/ml TNF-α and
200 µg/ml CML-collagen or control collagen was used, unless
stated otherwise.
Studies were undertaken to determine whether TNF-α or
CML-collagen stimulated DNA-binding activity of FOXO1
by  EMSA.  In  the  absence  of  TNF-α  or  CML-collagen
stimulation, insignificant amounts of FOXO1 activation were
detected in retinal pericytes (Figure 2). Incubation with TNF-
α (20 ng/ml) or CML-Collagen (200 μg/ml) induced FOXO1
DNA-binding  activity.  This  was  shown  to  be  specific  by
competitive inhibition with excess unlabeled FOXO1 probe
(Figure 2).
siRNA  studies  were  next  performed  to  establish  the
functional  role  of  FOXO1  activation  as  an  essential
component  in  TNF-α-stimulated  retinal  pericyte  apoptosis
(Figure 3). Cells were pre-incubated for 48 h with siRNA,
which was previously shown to be a strong FOXO1 silencer
(siRNA-A),  a  partial  silencer  (siRNA-B),  or  scrambled
siRNA, as discussed in the Methods section. In the presence
of siRNA-A, binding activity of FOXO1 in response to TNF-
Figure  1.  Tumor  necrosis  factor-alpha  (TNF-α)  and  Advanced
glycation endproduct (AGE) induce apoptosis in pericytes in vitro.
Primary bovine retinal pericytes were incubated with the indicated
concentration  of  (A)  TNF-α  (0–20  ng/ml)  or  (B)
carboxymethyllysine (CML)-collagen or unmodified collagen (0–
400 μg/ml) . Cells were lysed after 24 h and apoptosis was measured
by ELISA measurement of histone-associated cytoplasmic DNA.
C: Caspase-3 activity was measured by fluorometric assays in lysates
from cultured primary bovine retinal pericytes incubated with CML-
collagen, unmodified collagen (200 μg/ml), or TNF-α (20 ng/ml) for
24 h. Each value represents the mean of five replicates±standard error
of the mean. The experiment was performed three times with similar
results. *, p<0.05 significantly differs from control unstimulated
cells or unmodified control collagen.
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410α  (20  ng/ml)  stimulation  decreased  significantly,  while
siRNA-B had a partial effect and scrambled siRNA was not
able to decrease FOXO1 DNA-binding activity (Figure 3A).
To further investigate the functional role of FOXO1 activity
on TNF-α- or CML-collagen-induced apoptosis, we measured
pericyte apoptosis in the presence of different siRNAs. In the
absence  of  TNF-α  stimulation,  there  was  little  apoptosis,
which was not affected by transfection with siRNA-A (Figure
3B). TNF-α induced an eightfold increase in the level of
apoptosis (p<0.05). When transfected with strong silencing
siRNA-A, apoptosis was reduced approximately 71% and was
reduced by approximately 33% with moderately silencing
siRNA-B  (Figure  3A,B).  CML-collagen  stimulated  a
threefold increase in apoptosis (Figure 3C). Preincubation
with  FOXO1  siRNA-A  reduced  the  level  of  apoptosis  in
response to CML-collagen by 60% (p<0.05). Transfection per
se  was  not  responsible  for  the  reduced  apoptosis  since
scrambled siRNA had no effect (Figure 3C).
To gain insight into how TNF-α or an AGE might regulate
FOXO1 activation and apoptosis, specific inhibitors of the
MAP  kinase  signaling  pathway  were  used.  When  retinal
pericytes were preincubated with p38 or JNK inhibitors, TNF-
α-induced FOXO1 DNA-binding activity was substantially
reduced, as determined by EMSA (Figure 4A). A similar
result  was  obtained  in  response  to  AGE-induced  FOXO1
activation.  Specificity  was  demonstrated  by  competitive
inhibition with excess unlabeled probe (Figure 4A). The same
inhibitors were then used to determine the functional role of
p38 and JNK in TNF-α- or AGE-induced apoptosis (Figure
4B,C). TNF-α stimulated an eightfold increase in apoptosis.
Apoptosis was reduced approximately 63% and 38% when
cells  were  incubated  with  JNK  and  p38  inhibitors,
Figure 2. Forkhead box O1 (FOXO1) was activated in response to
Tumor  necrosis  factor  alpha  (TNF-α)  and  advanced  glycation
endproduct  (AGE)  in  retinal  pericytes.  Primary  bovine  retinal
pericytes  were  stimulated  with  TNF-α  (20  ng/ml),
carboxymethyllysine (CML)-collagen, or collagen (200 μg/ml) for 1
h. After nuclear extraction, activation of FOXO1 was measured by
electrophoretic mobility shift assay (EMSA). Unlabeled FOXO1 in
excess was used as a competitive inhibitor. A probe with nonspecific
sequence  (nonspecific  oligonucleotide)  was  used  as  a  negative
control. The experiment was performed three times with similar
results.
respectively.  However,  when  both  inhibitors  were  used
simultaneously, TNF-α-stimulated apoptosis was reduced by
Figure 3. Forkhead box O1 (FOXO1) plays a major role in tumor
necrosis factor-alpha (TNF-α)- or advanced glycation endproduct
(AGE)-induced apoptosis in retinal pericytes. A: Primary cultures of
retinal pericytes were transfected with different small interfering
RNAs (siRNAs) for 48 h. Cells were then stimulated with TNF-α
(20 ng/ml) for 1 h. After nuclear extraction, activation of FOXO1
was  measured  by  electrophoretic  mobility  shift  assay  (EMSA).
Unlabeled FOXO1 in excess was used as a competitive inhibitor. A
probe with nonspecific sequence (nonspecific oligonucleotide) was
used as a negative control. The experiment was performed three
times  with  similar  results.  B  and  C:  Primary  cultures  of  retinal
pericytes were transfected with different siRNAs for 48 h. Cells were
then stimulated by TNF-α (20 ng/ml B) or carboxymethyllysine
(CML)-collagen (200 μg/ml C) for 24 h. Apoptosis was determined
by  ELISA.  Each  value  represents  the  mean  of  three  replicates
±standard  error  of  the  mean  and  is  representative  of  three
experiments. *, p<0.05 significantly differs from control; **, p<0.05,
significantly differs from TNF-α- or CML-collagen-stimulated cells.
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41177%, which was greater than either inhibitor alone (p<0.05;
Figure 4B).
p38  inhibition  decreased  CML-collagen-induced
apoptosis 34%, and the JNK inhibitor decreased apoptosis by
41%, both of which were statistically significant (p<0.05;
Figure  4C).  However,  when  both  inhibitors  were  used
simultaneously,  CML-collagen-stimulated  apoptosis  was
reduced by 58%, which was greater than either inhibitor alone
Figure 4. Jun N-terminal kinase (JNK) and P38 inhibitors block
tumor necrosis factor (TNF)-induced Forkhead box O1 (FOXO1)
activation  and  apoptosis.  Primary  bovine  retinal  pericytes  were
preincubated with or without the p38 inhibitor or JNK inhibitor for
2 h, followed by TNF-α (20 ng/ml) or carboxymethyllysine (CML)-
collagen  (200  μg/ml)  stimulation.  A:  Activation  of  FOXO1  in
response to TNF-α or CML-collagen stimulation (1 h) was measured
by electrophoretic mobility shift assay (EMSA). Unlabeled FOXO1
in excess was used as a competitive inhibitor. B: Effect of JNK and
P38 inhibitors on TNF-α-induced apoptosis (24 h) was determined
by ELISA. C: Effect of JNK and P38 inhibitors on AGE-induced
apoptosis (24 h) was determined by ELISA. Each value represents
the  mean  of  three  replicates±standard  error  of  the  mean  and  is
representative of three experiments. *, p<0.05 significantly differs
from control (B) or control collagen (C); **, p<0.05, significantly
differs from TNF-α- or CML-collagen-stimulated cells.
(p<0.05; Figure 4C). Thus, both p38 and JNK arms of this
signaling  pathway  are  involved  in  CML-collagen-induced
apoptosis.  Doubling  the  concentration  of  p38  and  JNK
inhibitors did not significantly increase their inhibitory effect
on TNF-α- or CML-collagen-stimulated apoptosis (data not
shown).
Akt, also known as protein kinase B, inhibits apoptosis
through  multiple  mechanisms,  one  of  which  is  the
phosphorylation  of  FOXO1,  which  prevents  FOXO1
translocation to the nucleus [19]. Similarly, NF-κB in many
cell  types  is  directly  anti-apoptotic  [34].  We  further
investigated apoptosis by determining whether Akt or NF-κB
were  affecting  TNF-α-induced  apoptosis.  When  Akt  was
inhibited,  the  capacity  of  TNF-α  to  stimulate  apoptosis
increased  by  34%  (Figure  5A),  which  was  statistically
significant  (p<0.05).  To  investigate  the  role  of  NF-κB  in
apoptosis of pericytes, apoptosis of pericytes in the presence
of TNF-α and NF-κB inhibitor was measured. Inhibition of
NF-κB enhanced TNF-α-induced apoptosis by 41% (p<0.05;
Figure 5B).
DISCUSSION
Retinal capillaries are composed of pericytes and endothelial
cells.  Pericytes  and  their  processes  located  abluminally
surround a single layer of endothelial cells located luminally.
This unique localization allows pericytes to participate in the
control of retinal vascular contractility and tone [35,36]. The
studies of co-culture of endothelial cells and pericytes have
suggested  that  pericytes  have  both  anti-apoptotic  and
antiproliferative effects on endothelial cells [37]. The death
of pericytes is an early event in the pathogenesis of diabetic
retinopathy, and their loss is thought to compromise vessel
architecture, resulting in nonperfused acellular capillaries and
increased vascular leakiness [7]. The acellular capillaries, in
turn, contribute to ischemia and hypoxia of the retinal tissue,
a  negative  development  in  the  pathogenesis  of  diabetic
retinopathy  [10].  Mechanisms  proposed  to  account  for
pericyte apoptosis include rapid fluctuations of blood glucose
[38], increased Bax expression during hyperglycemia [39],
increased AGE formation [40], and TNF-α production [9].
Findings  from  this  study  suggest  that  FOXO1  is  an
important  regulator  of  pericyte  apoptosis  that  can  work
downstream of different apoptotic signals. Previously it was
shown that activation of FOXO1 induces the global induction
of pro-apoptotic genes and is thought to tilt the intracellular
balance  in  an  apoptotic  direction  [17,19,41].  In  vitro
experiments showed that in response to TNF-α and AGE
stimulation  retinal  pericytes  demonstrate  high  levels  of
FOXO1  DNA-binding  activity.  That  this  represents  a
mechanism for apoptosis in pericytes is supported by data that
shows  siRNA-mediated  silencing  of  FOXO1  inhibits
apoptosis. Interestingly, FOXO1 in diabetes is mostly known
for its effect on insulin regulation of glucose production and
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412insulin sensitivity [18,42,43]. Therefore, we suggest that the
elevation of FOXO1 in addition to other effects can play a role
in the pathogenesis of diabetic retinopathy through apoptosis
of  pericytes.  This  suggestion  is  supported  by  recently
published findings that FOXO1 DNA-binding activity and
nuclear translocation is enhanced in the microvascular cells
in the retinas of type 1 and type 2 diabetic rats and that
knockdown  of  FOXO1  by  siRNA  reduces  formation  of
acellular capillaries and pericyte ghosts [21].
NF-κB activation in pericytes of diabetic retinas is closely
linked  to  ocular  complications  of  diabetes  [44],  and  its
activation has been suggested as one of the mechanisms for
induction of apoptosis in retinal pericytes [44]. Our findings
Figure 5. Inhibition of AKT or nuclear factor kappa B (NF-κB)
enhances tumor necrosis factor-alpha (TNF-α)-induced apoptosis.
Primary bovine retinal pericytes were preincubated with or without
the Akt inhibitor, the specific NF-κB inhibitor (SN50), or the SN50M
control peptide that lacks activity for 2 h, followed by TNF-α (20 ng/
ml) stimulation in the presence of these molecules for 24 h. Apoptosis
was determined by ELISA. A: Effect of Akt inhibitor on TNF-α-
induced apoptosis was examined in pericytes. B: Effect of NF-κb
inhibitor on TNF-α-stimulated apoptosis in pericytes. Each value
represents the mean of three replicates±standard error of the mean
and is representative of three experiments. *, p<0.05 significantly
differs from the control; **, p<0.05, significantly differs from TNF-
α-stimulated cells.
indicate that inhibition of NF-κB directly increases apoptosis
in  the  pericytes  in  vitro,  which  suggests  that  NF-κB
contributes to cell survival. However, NF-κB may also have
indirect  effects,  particularly  in  a  complex  multicellular
environment where the inflammatory effects of NF-κB may
overcome its direct anti-apoptotic effects [34,45]. Recently
we reported that apoptotic balance within a cell depends on
the relative effects of NF-κB and FOXO1 activities [17]. TNF-
α induces FOXO1, which then stimulates pro-apoptotic gene
expression that occurs before apoptosis. Interestingly, TNF-α
also activates NF-κB, a survival transcription factor. This
would suggest that for TNF-α to induce apoptosis it must
overcome the effect of NF-κB-regulated “cell survival” genes,
a mechanism consistent with the need for FOXO1 activation.
That NF-κB inhibitors enhanced TNF-α-stimulated apoptosis
and  FOXO1  siRNA  inhibited  TNF-α-stimulated  apoptosis
suggests that this paradigm exists in pericytes and may be
particularly  important  in  TNF-α-stimulated  apoptosis.
Similarly, Akt is known to block the functional activity of the
FOXO transcription factors, including FOXO1 [42]. It has
been shown that during retinal degeneration inactivation of
Akt can contribute to apoptosis in photoreceptor cells [46].
This is in agreement with our findings that inhibition of Akt
further enhanced TNF-α-induced apoptosis, which indicates
that Akt functions as a survival factor in retinal pericytes.
Meanwhile,  inhibition  of  JNK  and  p38  MAP  kinases
substantially  reduced  the  capacity  of  TNF-α  to  activate
FOXO1.  We  also  found  that  TNF-α-induced  pericyte
apoptosis  was  dependent  upon  these  signaling  pathways.
Thus,  JNK  and  p38  may  have  pro-apoptotic  effects  that
include the activation of FOXO1.
Advanced glycation endproducts have been shown to
stimulate  cellular  activity,  including  apoptosis  through
Receptor  for  Advanced  Glycation  Endproducts  (RAGE)
signaling, and to activate NF-κB [15,28]. NF-κB activation
and apoptosis are stimulated in retinal endothelial cells by
advanced  glycation  endproducts  [47],  and  diabetic
retinopathy increases NF-κB activation, which is associated
with  RAGE  signaling  in  vivo  [46].  Although  it  is  well
documented that NF-κB is directly anti-apoptotic in many cell
types [45,48], NF-κB can indirectly promote apoptosis by
inducing apoptotic factors [44]. We found that AGEs can
stimulate activation of the transcription factor FOXO1, which
is directly pro-apoptotic. Findings that inhibitors of JNK and
p38 reduce AGE activation of FOXO1 suggests convergence
with the TNF-α stimulation at the MAP kinase pathway or
earlier. JNK and p38 may have pro-apoptotic effects that
include the activation of FOXO1, which is consistent with our
previous finding that showed that an AGE CML-collagen
induces apoptosis of fibroblasts through RAGE signaling and
activation of p38 and JNK MAP kinase pathways [22]. Thus,
studies  presented  here  indicate  AGEs  and  TNF-α  could
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413contribute to diabetic retinopathy through FOXO1-mediated
pericyte apoptosis.
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